EUVIMEDObjevte EUVIMED
Fallbericht

Primary localized cutaneous lichen myxedematosus with light chain‐restricted plasma cells: A distinct variant of the localized form of lichen myxedematosus

Shuo S Liu iD, Lily Park, Rehan Karim, Victoria Serralta, Giovanna Ciocca, Joseph S Susa, Andrew Hanly, Laszlo J Karai

Journal of Cutaneous Pathology · 2024

DOI: 10.1111/cup.14624 ↗

At a glance

Fallbericht in Journal of Cutaneous Pathology, 2024. Written by Shuo S Liu and 7 co-authors. Institution: Department of Dermatology, Larkin Community Hospital, South Miami, Florida, USA. Major MEDLINE topics: Plasma Cells, Scleromyxedema. 26 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Lichen myxedematosus (LM) is a chronic cutaneous mucinosis that can present as a localized skin lesion or as a generalized systemic disease termed scleromyxedema. The differential diagnosis is determined by a combination of clinical presentation, serological studies, and histopathological examination. Currently, well‐established and accepted histopathological features to distinguish localized LM from scleromyxedema have not been elucidated. Our recent publication, together with a retrospective literature review, suggests that the presence of groups of light chain‐restricted plasma cells represents a distinct histopathological clue for the diagnosis of localized LM. In this report, we provide two additional cases of localized LM with lambda light chain‐restricted plasma cells, together with clinical and histopathological findings that are similar to our previous publication. These cases support our theory that the light chain‐restricted plasmacytic microenvironment is primarily attributed to the pathogenesis of localized LM. Therefore, we consider these cases to constitute a clinically and pathologically new variant of localized LM and name it primary localized cutaneous LM with light chain‐restricted plasma cells.

Subjects

MeSH terms (MEDLINE)

Plasma CellsScleromyxedemaHumansFemaleMaleMiddle AgedDiagnosis, DifferentialAdultImmunoglobulin lambda-ChainsAged

Author keywords

cutaneous mucinosislichen myxedematosuslocalized lichen myxedematosusplasma cell light chain restrictionscleromyxedema

Substances

Immunoglobulin lambda-Chains

Authors and institutions

  • Department of Dermatology, Larkin Community Hospital, South Miami, Florida, USA.
  • Serralta Dermatology and Cutaneous Surgery, Arlington, Texas, USA.
  • Ciocca Dermatology, Miami, Florida, USA.
  • Global Pathology, Sonic Healthcare USA, Miami Lakes, Florida, USA.

ORCID profiles: Shuo S Liu

Cite

APA

Liu, S. S., Park, L., Karim, R., Serralta, V., Ciocca, G., Susa, J. S., Hanly, A., & Karai, L. J. (2024). Primary localized cutaneous lichen myxedematosus with light chain‐restricted plasma cells: A distinct variant of the localized form of lichen myxedematosus. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14624

Vancouver

Liu SS, Park L, Karim R, Serralta V, Ciocca G, Susa JS, et al. Primary localized cutaneous lichen myxedematosus with light chain‐restricted plasma cells: A distinct variant of the localized form of lichen myxedematosus. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14624

BibTeX
@article{Liu2024,
  author = {Liu, Shuo S and Park, Lily and Karim, Rehan and Serralta, Victoria and Ciocca, Giovanna and Susa, Joseph S and Hanly, Andrew and Karai, Laszlo J},
  title = {Primary localized cutaneous lichen myxedematosus with light chain‐restricted plasma cells: A distinct variant of the localized form of lichen myxedematosus},
  journal = {Journal of Cutaneous Pathology},
  year = {2024},
  doi = {10.1111/cup.14624}
}
Start for free →